These findings suggested that the inhibition of BRD4 followed by the down‐regulation of AURKA and AURKB could induce senescence in oesophageal cancer cells, which could be used as a new therapeutic target against oesophageal cancer. Here, AURKB is linked to carcinoma of esophagus.